Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (121-130 of 332) with videos related to

Pageof 34
Sort By:
European Urology Focus|May 2, 2019
Harnessing the Genomic Landscape of the Small Renal Mass to Guide Clinical ManagementAndrew W Silagy, Alejandro Sanchez, Brandon J Manley, et al.
European Urology Open Science|March 4, 2022
Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 CountriesRachel Giles, Deborah Maskens, Robert Bick, et al.
BJUI Compass|September 25, 2025
Staging CT chest for cT1a renal masses: Does it change management?Sanjana Ilangovan, Hannah Warren, Federica Sordelli, et al.
Urology|May 16, 2016
Survival in Patients With Primary Metastatic Renal Cell Carcinoma Treated With Sunitinib With or Without Previous Cytoreductive Nephrectomy: Results From a Population-based RegistrySaskia de Groot, William K Redekop, Stefan Sleijfer, et al.
The Journal of Urology|December 31, 2013
Penile sparing surgery for penile cancer-does it affect survival?Rosa S Djajadiningrat, Erik van Werkhoven, Wim Meinhardt, et al.
European Urology|October 28, 2008
Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysisManfred Johannsen, Anne Flörcken, Axel Bex, et al.
Lancet (London, England)|July 22, 2022
The multispeciality approach to the management of localised kidney cancerGrant D Stewart, Tobias Klatte, Laura Cosmai, et al.
European Urology|September 24, 2018
Epidemiology of Renal Cell CarcinomaUmberto Capitanio, Karim Bensalah, Axel Bex, et al.
World Journal of Urology|January 16, 2009
Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgeryAxel Bex, Astrid A M van der Veldt, Christian Blank, et al.
Turkish Journal of Urology|August 5, 2022
Current role of cytoreductive nephrectomy in metastatic renal cell carcinomaCharles Van Praet, Charlotte Slots, Nikhil Vasdev, et al.
Pageof 34

Showing results (121-130 of 332) with videos related to

Sort By:
Pageof 34
European Urology Focus|May 2, 2019
Harnessing the Genomic Landscape of the Small Renal Mass to Guide Clinical ManagementAndrew W Silagy, Alejandro Sanchez, Brandon J Manley, et al.
European Urology Open Science|March 4, 2022
Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 CountriesRachel Giles, Deborah Maskens, Robert Bick, et al.
BJUI Compass|September 25, 2025
Staging CT chest for cT1a renal masses: Does it change management?Sanjana Ilangovan, Hannah Warren, Federica Sordelli, et al.
Urology|May 16, 2016
Survival in Patients With Primary Metastatic Renal Cell Carcinoma Treated With Sunitinib With or Without Previous Cytoreductive Nephrectomy: Results From a Population-based RegistrySaskia de Groot, William K Redekop, Stefan Sleijfer, et al.
The Journal of Urology|December 31, 2013
Penile sparing surgery for penile cancer-does it affect survival?Rosa S Djajadiningrat, Erik van Werkhoven, Wim Meinhardt, et al.
European Urology|October 28, 2008
Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysisManfred Johannsen, Anne Flörcken, Axel Bex, et al.
Lancet (London, England)|July 22, 2022
The multispeciality approach to the management of localised kidney cancerGrant D Stewart, Tobias Klatte, Laura Cosmai, et al.
European Urology|September 24, 2018
Epidemiology of Renal Cell CarcinomaUmberto Capitanio, Karim Bensalah, Axel Bex, et al.
World Journal of Urology|January 16, 2009
Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgeryAxel Bex, Astrid A M van der Veldt, Christian Blank, et al.
Turkish Journal of Urology|August 5, 2022
Current role of cytoreductive nephrectomy in metastatic renal cell carcinomaCharles Van Praet, Charlotte Slots, Nikhil Vasdev, et al.
Pageof 34